市场调查报告书
商品编码
1615880
生命科学的云端运算IaaS的全球市场规模:各零件,各用途,部署模型,各地区,范围及预测Global Cloud Computing IaaS In Life Science Market Size By Component, By Application, By Deployment Model, By Geographic Scope And Forecast |
2024年生命科学云端运算IaaS市场规模为79.9亿美元,预计2031年将达到768.6亿美元,复合年增长率为32.70%。跨国和多州临床试验的激增、关键地区慢性病的流行以及基因疗法研究正在推动生命科学领域的云端运算 IaaS 市场。该研究报告对生命科学领域云端运算 IaaS 的全球市场进行了全面评估。它对关键细分市场、趋势、市场驱动因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。
生命科学领域云端运算 IaaS 的全球市场定义
生命科学产业依赖大量数据。因此,您需要一种有效、安全地储存资料的方法。使资料更易于存取的有效方法是使用基于云端的平台来储存资料和运行软体。这使得全球知识共享成为可能,加速这一进程,从而更快地部署疫苗、药物以及对化学和生物系统的理解。云端运算是一种按需提供资料储存和处理能力的电脑系统资源。
云端运算是一种按需提供资料储存和处理能力的电脑系统资源,也用于定义可供许多使用者透过网际网路存取的资料伺服器。云端运算的目的是节省资金并让客户专注于他们的业务目标,而不会受到 IT 问题的阻碍。基础设施即服务(IaaS)是一种提供运算资源的云端运算模型。基础设施即服务 (IaaS) 与软体即服务 (SaaS) 和平台即服务 (PaaS) 一起分类。基础设施即服务模型透过在本地资料中心託管基础设施元件来运作。
本地资料中心包括储存、网路硬体等。现代社会数位化的进步正在带动生命科学领域云端运算IaaS市场的成长。据称,研发疫苗需要10年时间。然而,随着全球知识共享和云端运算的出现,资料定位的障碍正在消失,这一步骤可能在一年内完成。此外,云端运算可以透过更快地回应患者需求来帮助患者获得更好的护理。
这是透过基于云端的平台实现的,该平台提供全球数据存取以有效共享知识,从而减少观察到的罕见案例。因此,早期介入和客製化治疗可加速患者復健。云端运算在生命科学产业中的众多优势之一是能够透过将 IT 维护和支援外包给云端供应商来最大限度地降低 IT 营运成本。这使得生命科学产业能够将资源用于重要目标,例如开发新疫苗和药物。
生命科学云端运算IaaS全球市场概况
跨国和多州临床试验的激增、关键地区慢性病的流行以及基因治疗研究正在推动生命科学研究的云端运算市场。药物开发的创新,例如个人化药物,需要从广泛的外部来源(包括患者、医生和付款人)收集和分析数据。这些因素正在推动对云端运算解决方案的需求。此外,该市场预计还将受益于合约研究组织、学术机构和医院等各种合作伙伴进行的临床试验数量的大幅增加。
与内部基础设施等传统IT基础设施相比,基础设施即服务中的云端运算也更加可靠。这些原因正在推动生命科学领域的云端运算 IaaS 市场。然而,对透过基于云端的模型捕获的患者资料的安全性的重大担忧以及缺乏对各行业隐私法规的适当遵守正在限制市场的成长。此外,由于运算解决方案针对特定需求的客製化程度不断提高以及云端运算中社群媒体的兴起,预计采用率将会加快。此外,许多国家慢性病的流行促使公司大力投资研发,以开发新的有针对性的治疗方法,为市场参与者创造了令人兴奋的机会。
Cloud Computing IaaS In Life Science Market size was valued at USD 7.99 Billion in 2024 and is projected to reach USD 76.86 Billion by 2031, growing at a CAGR of 32.70% during the forecast period 2024-2031. A surge in multinational and multistate clinical trials, widespread incidence of chronic diseases in major regions, and gene therapy research are driving the market for cloud computing IaaS in life science. The Global Cloud Computing IaaS In Life Science Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Cloud Computing IaaS In Life Science Market Definition
The life science industry functions on large volumes of data. As a result, it requires an efficient and secure means of storing the data. An effective way of making the data more accessible is by using cloud-based platforms for storing data and executing software. This allows processes to be accelerated because of the global knowledge-sharing created, which results in the faster rollout of vaccines, medicines, and an understanding of chemical and biological systems. Cloud computing is a computer system resource that provides data storage and processing capacity on demand.
It's also used to define data servers that are accessible over the internet to a large range of users. The goal of cloud computing is to save expenses and allow customers to focus on their business objectives rather than being blocked by IT problems. Infrastructure as a service, or IaaS, is a cloud computing model that provides computing resources. Infrastructure as a service (IaaS) is categorized along with software as a service (SaaS) and platform as a service (PaaS). The infrastructure as a service model works by hosting the infrastructure components in an on-premise data center.
The on-premise data center includes storage, networking hardware, and more. The increasing digitalization in today's society is leading to the growth of Cloud Computing IaaS In Life Science Market. Vaccine development might take up to ten years. However, owing to the advent of global knowledge sharing and cloud computing, that procedure may now be accomplished in a year by eliminating the barriers related to data location. Furthermore, cloud computing can help patients receive better treatment by allowing for a faster response to their needs.
This is accomplished by efficiently knowledge sharing by having a cloud-based platform to access data globally, which results in fewer rare cases being observed. As a result, patient recovery increases because of earlier intervention and customized treatment. One of the many benefits of cloud computing in the life science industry is the ability to minimize IT operational costs by outsourcing IT maintenance and support to the cloud provider. This allows the life science industry to reallocate resources towards key objectives such as developing new vaccines or medicines.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Cloud Computing IaaS In Life Science Market Overview
A surge in multinational and multistate clinical trials, widespread incidence of chronic diseases in major regions, and gene therapy research are driving the market for cloud computing in life sciences R&D. Drug development innovations, such as personalized medicines, necessitate the data collection and analysis from a wide range of external sources, including patients, physicians, and payers. The demand for cloud computing solutions is increasing as a result of this factor. Furthermore, the market is expected to benefit from a significant number of clinical trials conducted by various partners such as contract research organizations, academic institutions, and hospitals.
In comparison to traditional IT infrastructures, such as in-house infrastructure, cloud computing in infrastructure as a service is also much more reliable. These reasons are propelling the Cloud Computing IaaS In Life Science Market. However, significant security concerns of patient data obtained through cloud-based models, as well as a lack of proper compliance with various industry privacy regulations, have restrained the market's growth. Furthermore, the growing customization of computing solutions to meet specific needs and the rise of social media in cloud computing is expected to accelerate the adoption rate. In addition, the widespread incidence of chronic diseases in many countries has prompted companies to invest heavily in R&D to develop targeted and new therapies, opening exciting opportunities for market players.
The Global Cloud Computing IaaS In Life Science Market is Segmented on the basis of Component, Application, Deployment Model, And Geography.
Based on Component, The market is segmented into Software, Hardware, and Services. Hardware as a Service is another name for IaaS. (HaaS). It's one of the cloud computing platform's layers. Customers can outsource their IT infrastructures, such as servers, networking, processing, storage, virtual machines, and other resources, to the business. Customers access these resources on the Internet using a pay-as-per-use model.
Based on Application, The market is segmented into Nonclinical Information Systems (NCIS) and Clinical Information Systems. A non-clinical information system, often known as a hospital information system, is a computer system that manages, stores, and rechecks all medical information in hospitals, such as patient health history, prescriptions, and other special comments, all of which is stored electronically. Non-clinical systems aid decision-making and improve the efficiency and effectiveness of clinical care delivery, reducing paperwork.
Based on Deployment Model, The market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. A private cloud (also known as an internal cloud or corporate cloud) is a cloud computing environment in which all hardware and software resources are dedicated to a single customer and only that customer has access to them. Private cloud combines the elasticity, scalability, and ease of service delivery of cloud computing with the access control, security, and resource customization of on-premises infrastructure.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.